Abstract:Abstract Background: Macrophages arising from microglia and monocyte-derived macrophages (MDMs) have extensively studied and characterized in spinal corda injury. However, the infiltration of MDMs and the precise phenotypes of the two different populations during spinal cord ischemia and reperfusion injury (SCIRI), remains ambiguous. Methods: The SCIRI model was established by transient aortic occlusion followed by reperfusion. The Basso mouse scale (BMS) was used to quantify hind limb locomotion over the following three weeks. The histopathology of the spinal cord was evaluated by hematoxylin-eosin (HE) staining and NF-200 histochemistry. In addition, the expression of macrophage polarization phenotype were observed by double immunofluorescences, real-time PCR, and flow cytometry. Results: Compared with the Sham group, all mice in the SCIRI group developed acute paraplegia after reperfusion, gradually recovering neurological function by day 21. HE staining revealed that SCIRI induced evident pathological changes in the spinal cord. M1-type genes (iNOS, TNF-α, CD86, and CD16) were dramatically upregulated, mainly during the 1st week of SCIRI, whereas the M2 genes, CD206, and CD204, were elevated at a later stage. In addition, double-immunofluorescence confirmed in these activated microglia/macrophages phenotypes that CD86 and CD206 were co-localized. Finally, flow cytometry further demonstrated the infiltration of MDMs (CD11b+ CD45high cells) that were principally a pro-inflammatory M1 type, which peaked at day 3 and decreased by day 7 post-injury. Conversely, microglia (CD11b+CD45low cells), rather than invading MDMs, was the principal source of M2 polarized cells.Conclusions: SCIRI induced a transient influx of MDMs characterized by a M1 pro-inflammatory type, whereas resident microglia essentially maintained an M2 anti-inflammatory phenotype at later stage. These findings suggest that there is a differential regulatory role in the two cell populations following SCIRI.

Macrophages in Spinal Cord Injury: Phenotypic and Functional Change from Exposure to Myelin Debris.

Myelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury

Myelin Debris Stimulates Ng2/Cspg4 Expression In Bone Marrow-Derived Macrophages In The Injured Spinal Cord

The role of foam cells in spinal cord injury: challenges and opportunities for intervention

Targeting foamy macrophages by manipulating ABCA1 expression to facilitate lesion healing in the injured spinal cord

Microvascular endothelial cells engulf myelin debris and promote macrophage recruitment and fibrosis after neural injury

Current Knowledge of Microglia in Traumatic Spinal Cord Injury

PI3K signaling promotes formation of lipid-laden foamy macrophages at the spinal cord injury site

Dynamic development of microglia and macrophages after spinal cord injury

Distinct Polarization Dynamics of Microglia and Infiltrating Macrophages: A Novel Mechanism of Spinal Cord Ischemia/reperfusion Injury

Microglia coordinate cellular interactions during spinal cord repair in mice

Myelin Activates Fak/Akt/Nf-Kappa B Pathways and Provokes Cr3-Dependent Inflammatory Response in Murine System

Integrated multi-omics analysis reveals molecular changes associated with chronic lipid accumulation following contusive spinal cord injury

Effect of myelin debris on the phenotypic transformation of astrocytes after spinal cord injury in rats

Function of Microglia and Macrophages in Secondary Damage after Spinal Cord Injury

Advances in the research of the role of macrophage/microglia polarization-mediated inflammatory response in spinal cord injury

Unresolved Excess Accumulation of Myelin-derived Cholesterol Contributes to Scar Formation after Spinal Cord Injury

Prolonged inflammation leads to ongoing damage after spinal cord injury

The role and mechanisms of mesenchymal stem cells regulating macrophage plasticity in spinal cord injury

A Critical Role for Microglia in Regulating Metabolic Homeostasis and Neural Repair after Spinal Cord Injury

Hematogenous Macrophages: A New Therapeutic Target for Spinal Cord Injury